PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

advertisement
PharmTech Europe
25 February 2020

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

TOP STORIES

Researchers Discover Way of Continuously and Precisely Dosing Active Agents

Researchers at the Technical University of Munich (TUM) have discovered a way of continuously and precisely dosing active agents using an oil-hydrogel mixture.
/ read more /


Eli Lilly Completes Acquisition of Dermira for $1.1 Billion

Through the agreement, Lilly will expand its immunology pipeline with lebrikizumab, Dermira’s novel, investigational mAb designed to bind interleukin-13 with high affinity.
/ read more /


advertisement



Industry News

Virus Spread Threatens Pharmaceutical Supplies and Clinical Research

US and European regulatory officials continue to anticipate supply shortages in multiple areas.
/ read more /


CPhI South East Asia Rescheduled for July 2020

Ongoing coronavirus outbreak prompts date change to ensure safety of trade show participants.
/ read more /


More Industry News

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

Regulatory News

European Commission Issues Approval of Pfizer’s Vyndaqel

The European Commission (EC) has approved Pfizer’s treatment for wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM), Vyndaqel (tafamidis).
/ read more /


EMA’s PRAC Recommends Restricted Use of Cyproterone

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended that the use of cyproterone be restricted as a result of the potential risk of meningioma.
/ read more /


More Regulatory News

Bio/Pharma News

BIA Separations Signs License Agreement with University of Zagreb

Bio-chromatography development and manufacturing company, BIA Separations, has signed a license agreement with the University of Zagreb to commercialize a novel elution method for virus and viral vector purification.
/ read more /



GSK and Immatics in $550-Million+ Pact to Develop Adoptive Cell Therapies

The companies aim to develop novel cell therapies for treating multiple cancers.
/ read more /


More Bio/Pharma News

Supplier News

UK Government Designates Harwell Campus as Opportunity Zone

The Office for Life Sciences of the government of the United Kingdom has designated six new locations in the country as ‘Life Sciences Opportunity Zones’, of which the Harwell Science and Innovation Campus is one.
/ read more /



Aprecia to Partner with Purdue University for 3D Pharmaceutical Printing Projects

Aprecia, which has an FDA-approved 3D-printed medication, will collaborate with Purdue’s College of Pharmacy to accelerate development in 3DP pharmaceuticals.
/ read more /


More Supplier News

FEATURED TOPICS

ANALYTICAL METHOD DEVELOPMENT

Biopharma Analysis Benefits from New Technology and Methods

Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programmes to mitigate risk.
/ read more /

 

MANUFACTURING

Best Practices in Using Isolator Technology

Consider equipment design, transfer systems, and maintenance when operating isolators for sterile manufacturing of pharmaceutical products.
/ read more /

QUALITY SYSTEMS

Data Management Practices

Data management is crucial in bio/pharmaceutical laboratory settings from discovery steps through clinical studies and varies based on the development phase.
/ read more /

STANDARDS/REGULATIONS

ICH to Revise Quality Risk Management Guideline

ICH will be taking industry comments under consideration when it revises its Q9 guideline in order to clarify QRM requirements, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
/ read more /


PRODUCT PROFILES

Veltek Associates, Inc

Cart2CoreTM - Aseptic Cart Transferring System
VAI’s Cart2Core®, a patent pending technology, virtually eliminates the problematic issue of correct aseptic cart transference by making the cart top transferable to a new base at each new classification.
/ read more /

TAKE THE SURVEY

17th Annual BioPlan Associates' Biopharmaceutical Manufacturing Report

Expert input is needed for the bio-industry's most in-depth, global benchmarking and analysis study, which examines current global and regional trends affecting the bioindustry. Participants who complete the survey receive a free aggregated summary of the study results, a free whitepaper on the Top 15 Trends in Biopharmaceutical Manufacturing, and the opportunity to share insight about trends in biomanufacturing. For each completed survey, BioPlan Associates will contribute $10 (up to $3000) to a global health charity.
/ Take the survey /

 

Events

Bioprocessing Summit Europe

Barcelona, Spain

24–26 March 2020

SMI Group's 3rd Annual Injectable Drug Delivery Conference

London, UK

13–14 May 2020

more events

eBOOKS

Regulatory Sourcebook and Reference, September 2019

Pharmaceutical Technology’s Regulatory Sourcebook and Reference highlights regulatory trends and enforcement actions, risk-based studies for analytical procedure validation, and generic drug applications, as well as a detailed analysis of pharmacopoeia requirements, challenges with compliance.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise